FI882354A - Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi - Google Patents

Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi Download PDF

Info

Publication number
FI882354A
FI882354A FI882354A FI882354A FI882354A FI 882354 A FI882354 A FI 882354A FI 882354 A FI882354 A FI 882354A FI 882354 A FI882354 A FI 882354A FI 882354 A FI882354 A FI 882354A
Authority
FI
Finland
Prior art keywords
insulin
mixed crystals
des
human
preparing mixed
Prior art date
Application number
FI882354A
Other languages
English (en)
Swedish (sv)
Other versions
FI93797C (fi
FI882354A0 (fi
FI93797B (fi
Inventor
Michael Doerschung
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI882354A0 publication Critical patent/FI882354A0/fi
Publication of FI882354A publication Critical patent/FI882354A/fi
Application granted granted Critical
Publication of FI93797B publication Critical patent/FI93797B/fi
Publication of FI93797C publication Critical patent/FI93797C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI882354A 1987-05-22 1988-05-19 Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi FI93797C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873717370 DE3717370A1 (de) 1987-05-22 1987-05-22 Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
DE3717370 1987-05-22

Publications (4)

Publication Number Publication Date
FI882354A0 FI882354A0 (fi) 1988-05-19
FI882354A true FI882354A (fi) 1988-11-23
FI93797B FI93797B (fi) 1995-02-28
FI93797C FI93797C (fi) 1995-06-12

Family

ID=6328227

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882354A FI93797C (fi) 1987-05-22 1988-05-19 Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi

Country Status (20)

Country Link
US (1) US5028587A (fi)
EP (1) EP0291863B1 (fi)
JP (1) JPS63303930A (fi)
KR (1) KR880013572A (fi)
AT (1) ATE71842T1 (fi)
AU (1) AU601280B2 (fi)
CA (1) CA1335924C (fi)
DE (2) DE3717370A1 (fi)
DK (1) DK278088A (fi)
ES (1) ES2032896T3 (fi)
FI (1) FI93797C (fi)
GR (1) GR3004344T3 (fi)
HU (1) HU203840B (fi)
IE (1) IE60649B1 (fi)
IL (1) IL86452A (fi)
NO (1) NO175641C (fi)
NZ (1) NZ224715A (fi)
PH (1) PH25587A (fi)
PT (1) PT87523B (fi)
ZA (1) ZA883599B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
WO1992010284A2 (en) 1990-12-07 1992-06-25 Cnc Development, Inc. Catalytic chemical reactor
AU669110B2 (en) * 1991-05-24 1996-05-30 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US6004549A (en) * 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
NZ526672A (en) * 2001-02-09 2006-10-27 Genentech Inc Process for forming crystalline human insulin-like growth factor-1
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity
JP2010510988A (ja) * 2006-11-28 2010-04-08 マリナス ファーマシューティカルズ ナノ粒子製剤とその製造方法およびその利用
US9822158B2 (en) 2013-12-04 2017-11-21 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
EP3185887B1 (en) 2014-08-26 2021-03-10 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin or insulin analog compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
EG12098A (en) * 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
ATE71842T1 (de) 1992-02-15
EP0291863A2 (de) 1988-11-23
DE3867903D1 (de) 1992-03-05
DK278088A (da) 1988-11-23
IL86452A0 (en) 1988-11-15
HUT46546A (en) 1988-11-28
PH25587A (en) 1991-08-08
AU601280B2 (en) 1990-09-06
NO882207D0 (no) 1988-05-20
NO882207L (no) 1988-11-23
NO175641C (no) 1994-11-09
DE3717370A1 (de) 1988-12-01
IL86452A (en) 1993-02-21
ZA883599B (en) 1989-01-25
JPS63303930A (ja) 1988-12-12
HU203840B (en) 1991-10-28
AU1648788A (en) 1988-11-24
ES2032896T3 (es) 1993-03-01
FI93797C (fi) 1995-06-12
NZ224715A (en) 1990-04-26
EP0291863A3 (en) 1990-04-04
US5028587A (en) 1991-07-02
GR3004344T3 (fi) 1993-03-31
FI882354A0 (fi) 1988-05-19
IE60649B1 (en) 1994-08-10
PT87523A (pt) 1989-05-31
IE881522L (en) 1988-11-22
KR880013572A (ko) 1988-12-21
EP0291863B1 (de) 1992-01-22
DK278088D0 (da) 1988-05-20
NO175641B (fi) 1994-08-01
FI93797B (fi) 1995-02-28
PT87523B (pt) 1992-09-30
CA1335924C (en) 1995-06-13

Similar Documents

Publication Publication Date Title
FI93797B (fi) Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
IL72469A (en) Insulin derivatives,process for their preparation and pharmaceutical compositions for the treatment of diabetes mellitus
FI881061A0 (fi) Kompositioner med foerdroejd frigoerelse foer parenteralt bruk och deras anvaendning.
YU101385A (en) Process for obtaining crystal calcium pseudomonate or its hydrate
KR880701738A (ko) Co₂처리에 의한 알기네이트 또는 타 우론산의 변형
FI885488A (fi) 2,2-difluorisyklopropyylietaanijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö tuholaisten torjunta-aineina
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
FI875340A0 (fi) Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
JPS645460A (en) Production of delaying gelatinous material
FI98782B (fi) Kurkuliini-proteiini, menetelmä sen valmistamiseksi ja sen käyttö
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
SE8703512D0 (sv) Medel for tandbehandling
UA8036A1 (uk) Спосіб одержання похідних тіазолу або їх кислотно-аддітивних солей
SU1840597A1 (ru) Способ получения бис-(хлороксимино)-ацетона
IT209407Z2 (it) Apparecchio per il trattamento terapeutico dei linfedemi degli arti mediante microonde.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT